Windtree Therapeutics, Inc. (WINT)

NASDAQ: WINT · IEX Real-Time Price · USD

3.610

-0.120 (-3.22%)

At close: Jul 19, 2024, 4:00 PM

4.000

+0.390 (10.80%)

Pre-market: Jul 22, 2024, 6:56 AM EDT

Windtree Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1995
Revenue	0	0	0	0	0	0.2	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	-88.93%	Upgrade
Gross Profit	0	0	0	0	0	0.2	Upgrade
Selling, General & Admin	9.06	9.2	10.79	14.47	14.94	12.4	Upgrade
Research & Development	9.18	8.34	11.1	17.79	15.37	12.69	Upgrade
Other Operating Expenses	2.57	3.06	19.44	45.02	0	0	Upgrade
Operating Expenses	20.81	20.6	41.33	77.28	30.32	25.09	Upgrade
Operating Income	-20.81	-20.6	-41.33	-77.28	-30.32	-24.89	Upgrade
Interest Expense / Income	0.05	0.05	0.05	0.11	0.13	0.5	Upgrade
Other Expense / Income	-15.02	-0.36	-0.81	0.23	2.12	2.09	Upgrade
Pretax Income	-5.85	-20.29	-40.58	-77.62	-32.57	-27.48	Upgrade
Income Tax	0.11	0	-1.37	-9.99	0	0	Upgrade
Net Income	-5.96	-20.29	-39.21	-67.64	-32.57	-27.48	Upgrade
Shares Outstanding (Basic)	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	0	0	Upgrade
Shares Change	868.75%	515.24%	27.27%	58.11%	43.25%	629.69%	Upgrade
EPS (Basic)	-36.34	-94.32	-1120.14	-2459.52	-1872.00	-2259.00	Upgrade
EPS (Diluted)	-36.34	-94.32	-1120.14	-2459.52	-1872.00	-2259.00	Upgrade
Free Cash Flow	-13.88	-13.45	-19.26	-23.94	-25.61	-24.85	Upgrade
Free Cash Flow Per Share	-29.85	-62.47	-550.14	-870.65	-1472.20	-2046.94	Upgrade
Gross Margin	-	-	-	-	-	100.00%	Upgrade
Operating Margin	-	-	-	-	-	-12572.22%	Upgrade
Profit Margin	-	-	-	-	-	-13876.26%	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-12552.53%	Upgrade
EBITDA	-5.32	-19.75	-39.46	-76.64	-31.8	-25.87	Upgrade
EBITDA Margin	-	-	-	-	-	-13064.65%	Upgrade
Depreciation & Amortization	0.47	0.49	1.06	0.87	0.64	1.11	Upgrade
EBIT	-5.8	-20.24	-40.52	-77.51	-32.44	-26.98	Upgrade
EBIT Margin	-	-	-	-	-	-13626.26%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).